RB faces Nurofen class action in Australia

7 March 2016 - Deborah Wilkes

Archived

RB is facing a class action in Australia following the recent court ruling that four of the company's Nurofen products had made "misleading" specific-pain claims. In a separate development, RB has withdrawn television advertising for Nurofen Express in the UK following an investigation by the Advertising Standards Authority (ASA).

Click tags below for more information on topics:

PAGB

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: